Novo Nordisk | DEBITO



Debt Cambiamento Data
ANI Pharmaceuticals USD 624.09M 304.02M 2024-12
Aurora Cannabis CAD 100.98M 11K 2024-12
Bausch Health Companies USD 21.51B 153M 2024-09
Bristol-Myers Squibb USD 49.71B 62M 2025-03
Canopy Growth CAD 489.67M 123.85M 2024-12
Corcept Therapeutics USD 0 0 2024-12
Drreddys Laboratories INR 51.08B 2.55B 2024-12
Eli Lilly USD 33.64B 2.52B 2024-12
GlaxoSmithKline GBP 16.99B 927M 2024-12
Merck USD 37.11B 1.02B 2024-12
Novartis USD 31.26B 828M 2024-12
Novo Nordisk 56.97B 88M 2024-09
Novo Nordisk DKK 56.97B 88M 2024-09
Pacira USD 585.32M 2.04M 2024-12
Perrigo USD 3.62B 1.14B 2024-12
Prestige Brands USD 996.95M 54.86M 2024-12
Sanofi 21.05B 3.14B 2025-03
Supernus Pharmaceuticals USD 0 0 2024-12
Zoetis USD 6.57B 4M 2024-12



Novo Nordisk DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.